Correlation Between Madrigal Pharmaceuticals and Kronos Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Kronos Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Kronos Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Kronos Bio, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Kronos Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Kronos Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Kronos Bio.

Diversification Opportunities for Madrigal Pharmaceuticals and Kronos Bio

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Madrigal and Kronos is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Kronos Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kronos Bio and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Kronos Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kronos Bio has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Kronos Bio go up and down completely randomly.

Pair Corralation between Madrigal Pharmaceuticals and Kronos Bio

Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 1.56 times more return on investment than Kronos Bio. However, Madrigal Pharmaceuticals is 1.56 times more volatile than Kronos Bio. It trades about 0.24 of its potential returns per unit of risk. Kronos Bio is currently generating about -0.05 per unit of risk. If you would invest  21,243  in Madrigal Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of  13,275  from holding Madrigal Pharmaceuticals or generate 62.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Madrigal Pharmaceuticals  vs.  Kronos Bio

 Performance 
       Timeline  
Madrigal Pharmaceuticals 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Madrigal Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Madrigal Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.
Kronos Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kronos Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Madrigal Pharmaceuticals and Kronos Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Madrigal Pharmaceuticals and Kronos Bio

The main advantage of trading using opposite Madrigal Pharmaceuticals and Kronos Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Kronos Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kronos Bio will offset losses from the drop in Kronos Bio's long position.
The idea behind Madrigal Pharmaceuticals and Kronos Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Fundamental Analysis
View fundamental data based on most recent published financial statements
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance